Announced
Synopsis
Oaktree, an investment firm, agreed to invest $150m in Draslovka, a manufacturer of cyanide-based chemical specialties and agricultural chemicals. “We are delighted to enter into the strategic partnership with Oaktree as we look to deliver on our ambitious growth strategy. Oaktree brings significant investment expertise and a broad industry knowledge to Draslovka, and this investment is not only a strong endorsement of the success we have delivered to date but an indication that there is much more to come. We look forward to working alongside Oaktree as we deliver on our ambitious growth targets," Pavel Brůžek, Draslovka CEO
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.